Anti, while it might not be a good idea to squirt Betadine up your nose you’ve missed the point: Covid is not Firebrick’s main target illness, the common cold is. Phase 3 human data supports Nasodine’s effectiveness against colds (which have been with us forever) and confirmatory testing will happen this year. Nowhere in the prospectus or interviews I’ve seen does Firebrick claim that Nasodine works against Covid. That doesn’t mean it won’t of course, and a Phase 2 trial is planned for this year to find out, but Firebrick developed Nasodine to prevent colds or at least minimise their symptoms, and if it can do either of those things it’s a real bio-science company-maker.
FRE Price at posting:
40.5¢ Sentiment: Hold Disclosure: Held
